subretinal fluid
Showing 1 - 25 of 5,955
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Recruiting
- Polypoidal Choroidal Vasculopathy
- +2 more
- Intravitreal aflibercept injection
-
Seoul, Korea, Republic ofJae Hui Kim
Dec 20, 2022
Perfluorooctyl Bromide Which Empowers Liquid to Flat Detached
Recruiting
- Retinal Disease
-
Cairo, Kubri EL Kubba, EgyptGirgis Boules
Jan 24, 2023
Acute Central Serous Retinopathy With Subretinal Fluid Trial in Minya (Micropulse laser)
Completed
- Acute Central Serous Retinopathy With Subretinal Fluid
- Micropulse laser
-
Minya, Minia, EgyptMinia University Hospital
Sep 8, 2022
Vitreomacular Traction, Subretinal Edema Trial in Norfolk (Eplerenone)
Terminated
- Vitreomacular Traction
- Subretinal Edema
-
Norfolk, VirginiaWagner Macula & Retina Center
Jan 6, 2021
Retinal Vein Occlusion, Diabetic Macular Edema Trial in Beverly Hills, Boston (KPI-121 0.25% Ophthalmic Suspension, KPI-121 1.0%
Completed
- Retinal Vein Occlusion
- Diabetic Macular Edema
- KPI-121 0.25% Ophthalmic Suspension
- KPI-121 1.0% Ophthalmic Suspension
-
Beverly Hills, California
- +1 more
Dec 9, 2020
Single Injection of Faricimab for nAMD With Persisting Fluid
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Glostrup, DenmarkMiklos Schneider
Nov 3, 2023
Central Serous Chorioretinopathy Trial (100µm laser spot diameter micropulse laser, 200µm laser spot diameter micropulse laser)
Not yet recruiting
- Central Serous Chorioretinopathy
- 100μm laser spot diameter micropulse laser
- 200μm laser spot diameter micropulse laser
- (no location specified)
Jan 13, 2023
Retina Detachment Trial in Brescia (Scleral Buckling, Drainage-Injection-Pneumoretinopexy)
Completed
- Retina Detachment
- Scleral Buckling
- Drainage-Injection-Pneumoretinopexy
-
Brescia, BS, ItalySpedali Civili di Brescia
Oct 23, 2019
Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)
Completed
- Choroidal Neovascularization
-
Sao Paulo, BrazilHospital das Clínicas- University of Sao Paulo
Jan 4, 2022
Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)
Recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept 40 MG/ML
- Faricimab 120 MG/ML
-
Graz, Styria, AustriaDepartment of Ophthalmolgy, Medical University Graz
Jul 3, 2023
Age-Related Macular Degeneration Trial in Beijing (KH631)
Not yet recruiting
- Age-Related Macular Degeneration
-
Beijing, ChinaBeijing Tongren Hospital, Capital Medical University
Jan 3, 2023
Diabetic Macular Edema Trial (RC-28E, Aflibercept)
Not yet recruiting
- Diabetic Macular Edema
- RC-28E
- Aflibercept
- (no location specified)
May 30, 2023
Achromatopsia Trial in Tuebingen (rAAV.hCNGA3)
Recruiting
- Achromatopsia
-
Tuebingen, GermanyUniversity Hospital Tuebingen, Center for Ophthalmology
Dec 7, 2022
Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Aflibercept Ophthalmic
- IBI302
-
Suzhou, Jiangsu, ChinaInnovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023
Diabetic Retinopathy, Vitreomacular Traction Trial in Minya (Methotrexate 25 MG/ML, parsplana vitrectomy)
Recruiting
- Diabetic Retinopathy
- Vitreomacular Traction
- Methotrexate 25 MG/ML
- parsplana vitrectomy
-
Minya, Minia, Egyptophthalmology department, Minia university hospital
Sep 8, 2023
Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)
Recruiting
- Wet Age-related Macular Degeneration
-
Beijing, Beijing, ChinaBeijing Hospital
Feb 3, 2023
CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea
Active, not recruiting
- AMD
- Exudative Macular Degeneration
-
Bordeaux, France
- +4 more
Dec 2, 2022
naïve Age-related Macular Degeneration Neovascular Type and
Completed
- Macular Degeneration
- Data extraction from medical files
-
Brussels, BelgiumCHU Brugmann
Mar 7, 2022
Retinal Disease, Retinitis Pigmentosa Trial in Riyadh (Subretinal administration of rAAV2-VMD2-hMERTKRecombinant
Completed
- Retinal Disease
- Retinitis Pigmentosa
- Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Jan 25, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)
Recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Los Angeles, California
- +11 more
Jan 11, 2023
Usher Syndrome, Retinitis Pigmentosa Trial in Portland, Paris (SAR421869)
Terminated
- Usher Syndrome
- Retinitis Pigmentosa
-
Portland, Oregon
- +1 more
Mar 30, 2022
Choroidal Blood Flow in Acute and Chronic Central Serous
Recruiting
- Central Serous Chorioretinopathy
-
Stavanger, NorwayStavanger University Hospital, Department of Ophthalmology
Oct 18, 2022
Macular Holes Trial (3 Days of face-down positioning, 7 Days of face-down positioning)
Not yet recruiting
- Macular Holes
- 3 Days of face-down positioning
- 7 Days of face-down positioning
- (no location specified)
Aug 13, 2023
Brolucizumab in Pre-treated nAMD in the Real-world Setting
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Brolucizumab
- (no location specified)
Aug 8, 2022